154 related articles for article (PubMed ID: 8834172)
1. Novel mitochondrial DNA deletion found in a renal cell carcinoma.
Horton TM; Petros JA; Heddi A; Shoffner J; Kaufman AE; Graham SD; Gramlich T; Wallace DC
Genes Chromosomes Cancer; 1996 Feb; 15(2):95-101. PubMed ID: 8834172
[TBL] [Abstract][Full Text] [Related]
2. Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma.
Selvanayagam P; Rajaraman S
Lab Invest; 1996 Mar; 74(3):592-9. PubMed ID: 8600309
[TBL] [Abstract][Full Text] [Related]
3. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
Bugert P; Wilhelm M; Kovacs G
Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
[TBL] [Abstract][Full Text] [Related]
4. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome.
Kempkensteffen C; Hinz S; Schrader M; Christoph F; Magheli A; Krause H; Schostak M; Miller K; Weikert S
Cancer Lett; 2007 Sep; 254(2):227-35. PubMed ID: 17449173
[TBL] [Abstract][Full Text] [Related]
5. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
[TBL] [Abstract][Full Text] [Related]
6. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas.
Nagy A; Wilhelm M; Sükösd F; Ljungberg B; Kovacs G
Genes Chromosomes Cancer; 2002 Nov; 35(3):256-60. PubMed ID: 12353267
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
8. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
10. Mutations of mtDNA in renal cell tumours arising in end-stage renal disease.
Nagy A; Wilhelm M; Kovacs G
J Pathol; 2003 Feb; 199(2):237-42. PubMed ID: 12533837
[TBL] [Abstract][Full Text] [Related]
11. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
[TBL] [Abstract][Full Text] [Related]
12. [Screening of novel genes differentially expressed in human renal cell carcinoma by suppression subtractive hybridization].
Ai JK; Huang X; Wang YJ; Bai Y; Lu YQ; Ye XJ; Xin DQ; Na YQ; Zhang ZW; Guo YL
Ai Zheng; 2002 Oct; 21(10):1065-9. PubMed ID: 12508644
[TBL] [Abstract][Full Text] [Related]
13. PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease.
Sandy MS; Langston JW; Smith MT; Di Monte DA
Mov Disord; 1993; 8(1):74-82. PubMed ID: 8419811
[TBL] [Abstract][Full Text] [Related]
14. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
16. Differential protein profiling in renal-cell carcinoma.
Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
[TBL] [Abstract][Full Text] [Related]
17. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
[TBL] [Abstract][Full Text] [Related]
18. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
19. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
Hu LT; Stamberg J; Pan S
Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
